Platelet-rich Blood Derivatives for Tendon Regeneration.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31596744.
- Also identified by DOI 10.5435/JAAOS-D-18-00638.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tendon injuries constitute a significant healthcare problem with variable clinical outcomes. The complex interplay of tissue homeostasis, degeneration, repair, and regeneration makes the development of successful delivery therapeutic strategies challenging. Platelet-rich hemoderivatives, a source of supra-physiologic concentrations of human therapeutic factors, are a promising application to treat tendon injuries from the perspective of tendon tissue engineering, although the outcomes remain controversial.
Medical subject headings
- Platelet-Rich Plasma
- Regeneration
- Tendon Injuries
- Tissue Engineering